Novel Therapeutic Strategies and Targets in Rheumatoid Arthritis
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".
Deadline for manuscript submissions: 31 January 2027 | Viewed by 358
Special Issue Editors
Interests: rheumatoid arthritis; immunotherapy; CD6
Special Issue Information
Dear Colleagues,
The scope of this Special Issue covers the interaction between exogenous agents or subtances and the cells and molecules that drive tissue inflammation and damage in the joints of patients with rheumatoid arthritis (RA), and/or the manifestations of RA in other organs. Bioactive components may be environmental factors that affect the risk of RA, alterations in host microbiomes or diet that influence the onset and course of RA, or the properties of novel therapeutic vehicles such as nanoparticles in the treatment of RA. This topic includes human RA and its animal models.
To present and review advances in RA research that could influence future treatment and outcomes of RA.
Potential topics
- Environmental control of epigenetic alterations in RA.
- Environmental factors in pulmonary aspects of RA.
- Which microbiome(s) controls RA?
- Diet and RA.
- Novel inflammatory mediators and their receptors in RA joints.
- Natural substances as new anti-inflammatory drugs or DMARDs for the treatment of RA.
- Targeting the RA joint using nanoparticles.
Suggestions for additional topics are welcome.
Prof. Dr. David Fox
Prof. Dr. James J. Moon
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- RA
- synovium
- FLS
- synovial fluid
- microbiome
- autoimmunity
- DMARD
- joint inflammation
- joint damage
- nanoparticle
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
